Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Carpenter Technology
CRS
$25.8B
| $25.8M | 0.01% |
641,760
+6,489
| +1% | +$274K |
|
|
AYX
1377
DELISTED
Alteryx Inc
AYX
| $25.8M | 0.01% |
299,789
+7,339
| +3% | +$600K |
|
|
GTM
1378
ZoomInfo Technologies
GTM
$973M
| $25.8M | 0.01% |
494,213
+57,369
| +13% | +$2.7M |
|
1379
Healthcare Services Group
HCSG
$1.6B
| $25.8M | 0.01% |
815,654
+35,315
| +5% | +$1.07M |
|
|
SAVE
1380
DELISTED
Spirit Airlines, Inc.
SAVE
| $25.7M | 0.01% |
845,354
+37,079
| +5% | +$1.3M |
|
1381
Westlake Corp
WLK
$9.03B
| $25.7M | 0.01% |
285,553
-2,631
| -0.9% | -$256K |
|
|
BRSL
1382
Brightstar Lottery PLC
BRSL
$1.84B
| $25.7M | 0.01% |
1,073,300
-72,438
| -6% | -$1.52M |
|
1383
First Bancorp
FBP
$4.42B
| $25.7M | 0.01% |
2,156,978
-164,673
| -7% | -$2.03M |
|
1384
Quaker Houghton
KWR
$2.76B
| $25.7M | 0.01% |
108,199
+2,391
| +2% | +$572K |
|
|
UFS
1385
DELISTED
DOMTAR CORPORATION (New)
UFS
| $25.7M | 0.01% |
466,761
-43,427
| -9% | -$2.1M |
|
1386
Kinsale Capital Group
KNSL
$8.12B
| $25.6M | 0.01% |
155,604
+2,899
| +2% | +$478K |
|
1387
Cannae Holdings
CNNE
$639M
| $25.6M | 0.01% |
755,593
+33,997
| +5% | +$1.27M |
|
1388
Adaptive Biotechnologies
ADPT
$3.59B
| $25.6M | 0.01% |
625,869
+22,562
| +4% | +$877K |
|
|
ESGR
1389
DELISTED
Enstar Group
ESGR
| $25.6M | 0.01% |
106,988
+5,986
| +6% | +$1.49M |
|
1390
Myriad Genetics
MYGN
$270M
| $25.6M | 0.01% |
835,560
+15,082
| +2% | +$436K |
|
|
DCH
1391
Dauch Corp
DCH
$1.34B
| $25.5M | 0.01% |
2,467,952
+138,460
| +6% | +$1.46M |
|
1392
First Commonwealth Financial
FCF
$2.18B
| $25.4M | 0.01% |
1,805,920
+134,338
| +8% | +$1.97M |
|
1393
Ashland
ASH
$3.33B
| $25.4M | 0.01% |
290,097
+6,455
| +2% | +$581K |
|
1394
Brady Corp
BRC
$4.44B
| $25.4M | 0.01% |
452,772
+20,900
| +5% | +$1.18M |
|
1395
Belden
BDC
$4.85B
| $25.3M | 0.01% |
500,879
+14,802
| +3% | +$723K |
|
1396
Qualys
QLYS
$5.1B
| $25.3M | 0.01% |
251,307
-3,666
| -1% | -$373K |
|
|
MNDT
1397
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $25.3M | 0.01% |
1,251,074
+28,594
| +2% | +$586K |
|
|
CTEV
1398
Claritev Corp
CTEV
$387M
| $25.3M | 0.01% |
66,412
+22,216
| +50% | +$6.88M |
|
1399
Kratos Defense & Security Solutions
KTOS
$8.74B
| $25.3M | 0.01% |
886,564
+34,543
| +4% | +$913K |
|
1400
Ameris Bancorp
ABCB
$5.85B
| $25.2M | 0.01% |
497,202
+20,064
| +4% | +$1.08M |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.